| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.022 | 0.4 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |